Faculty, Staff and Student Publications

Language

English

Publication Date

4-13-2023

Journal

BMC Ophthalmology

DOI

10.1186/s12886-023-02893-6

PMID

37055797

PMCID

PMC10103399

PubMedCentral® Posted Date

April 2023

PubMedCentral® Full Text Version

Post-print

Abstract

BACKGROUND: To evaluate the safety of different doses of subconjunctival cetuximab in rabbits.

METHODS: After general anesthesia rabbits received a subconjunctival injection of 2.5 mg in 0.5 ml, 5 mg in 1 ml, and 10 mg in 2 ml of cetuximab in their right eyes (two rabbits in each group). A similar volume of normal saline solution was injected subconjunctivally in the left eyes. The histopathologic changes were evaluated after enucleation with the aid of H&E staining.

RESULTS: No significant difference were observed between the treated and control eyes in terms of conjunctival inflammation, goblet cell density, or limbal blood vessel density for all administered doses of cetuximab.

CONCLUSION: Subconjunctival injection of cetuximab with the administrated doses in rabbit eyes are safe.

Keywords

Ocular surface squamous neoplasia, Intraepithelial neoplasia, Cetuximab

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.